Ischemic neuronal death in the rat hippocampus: The calpain-calpastatin-caspase hypothesis

Neurobiology of Disease

Volumn 13, Issue 2, 2003, Pages 75-88

  Rami, A ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Apoptosis; Calpain; Calpastatin; Caspase; Cerebral ischemia; Hippocampus; Necrosis; Selective vulnerability

Indexed keywords

APOPTOSIS INDUCING FACTOR; APOPTOTIC PROTEASE ACTIVATING FACTOR 1; CALPAIN; CALPASTATIN; CARRIER PROTEIN; CASPASE 3; CASPASE 7; CASPASE 9; CASPASE INHIBITOR; CYTOSKELETON PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN; MEMBRANE RECEPTOR; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PHOSPHOTRANSFERASE; PRESENILIN 1; PRESENILIN 2; PROTEIN BCL 2;

APOPTOSIS; BRAIN ISCHEMIA; ENZYME ACTIVATION; ENZYME SUBSTRATE; HIPPOCAMPUS; HOMEOSTASIS; HYPOTHESIS; HYPOXIA; MOLECULAR INTERACTION; NERVE CELL NECROSIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW;

EID: 0038725886     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-9961(03)00018-4     Document Type: Review

References (136)

1. Adida C., Berrebi D., Peuchmaur M., Reyes-Mugica M., Altieri D.C. Anti-apoptosis gene, survivin, and prognosis of neuroblastoma. Lancet. 351:1998;882-883.
2. Bahr B.A., Abai B., Gall C.M., Vanderklish P.W., Hoffman K.B., Lynch G. Induction of β-amyloid-containing polypeptides in hippocampus evidence for a concomitant loss of synaptic proteins and interactions with an excitotoxin . Exp. Neurol. 129:1994;81-94.
3. Banik N.L., Shields D.C. A putative role for calpain in demyelination associated with optic neuritis. Histol. Histopathol. 14:1999;649-656.
4. Bartus R.T., Hayward N.J., Elliot P.J., Sawyer S.D., Baker K.L., Dean R.L., Akiyama A., Straub J.A., Harbeson S.H., Li Z., Powers J. Calpain inhibitor AK295 protects neurons from focal brain ischemia effects of postocclusion intra-areterial administration . Stroke. 25:1994;2265-2270.
5. Behrens M.M., Martinez J.L., Moratilla C., Renart J. Apoptosis induced by protein kinase C inhibition in a neuroblastoma cell line. Cell Growth Differ. 6:1995;1375-1380.
6. Bhat R.T., DiRocco R., Marcy V.R., Flood D.G., Zhu Y., Dobrzanski P., Siman R., Scott R., Contreras P.C., Miller M. Increased expression of IL-1β converting enzyme in hippocampus after ischemia selective localization in microglia . J. Neurosci. 16:1996;4146-4154.
7. Bi X., Bi R., Baudry M. Calpain-mediated truncation of glutamate ionotropic receptors. Methods for studying the effects of calpain activation in brain tissue. Methods Mol. Biol. 144:2000;203-217.
8. Billger M., Wallin M., Karisson J.O. Proteolysis of tubulin and microtubule-associated proteins 1 and 2 by calpain I and II. Difference in sensitivity of assembled and disassembled microtubules. Cell Calcium. 9:1988;33-44.
9. Blomgren K., Hallin U., Andersson A.L., Puka-Sundvall M., Bahr Ben A., McRae A., Saido T.C., Kawashima S., Hagberg H. Calpastatin is up-regulated in response to hypoxia and is a suicide substrate to calpain after neonatal cerebral hypoxia-ischemia. J. Biol. Chem. 274:1999;14046-14052.
10. Blomgren K., Zhu C., Wang X., Karlsson J.O., Leverin A.L., Bahr B.A., Mallard C., Hagberg H. Synergistic activation of caspase-3 by m-calpain after neonatal hypoxia-ischemia a mechanism of "pathological apoptosis"? J. Biol. Chem. 276:2001;10191-10198.
11. Brown S.B., Bailey K., Savill J. Actin is cleaved during constitutive apoptosis. Biochem. J. 323:1997;233-237.
12. Carillo S., Pariat M., Steff A.M., Roux P., Etienne-Julan M., Lorca T., Piechaczyk M. Differential sensitivity of FOS and JUN family members to calpains. Oncogene. 9:1994;1679-1689.
13. Chan S.L., Griffin W.S., Mattson M.P. Evidence for caspase-mediated cleavage of AMPA receptor subunits in neuronal apoptosis and Alzheimer's disease. J. Neurosci. Res. 57:1999;315-323.
14. Charriaut-Marlangue C., Margaill I., Represa A., Popovici T., Plotkine M., Ben-Ari Y. Apoptosis and necrosis after reversible focal ischemia an in situ DNA fragmentation analysis . J. Cereb. Blood Flow Metab. 16:1996;86-194.
15. Chen J., Nagayama T., Jin K., Stetler R.A., Zhu R.L., Graham S.H., Simon R.P. Induction of caspase-3-like protease may mediate delayed neuronal death in the hippocampus after transient cerebral ischemia. J. Neurosci. 18:1998;4914-4928.
16. Cheng C.H., Kirsch D.G., Clem R.J., Ravi R., Kastan M.B., Bedi A., Ueno K., Hardwick J.M. Conversion of bcl-2 to a bax-like death effector by caspases. Science. 278:1997;1966-1968.
17. Choi D.W. Glutamate neurotoxicity and diseases of the nervous system. Trends Neurosci. 11:1988;465-469.
18. Chopp M., Li Y., Zhang Z.G., Freytag S.O. p53 expression in brain after middle cerebral artery occlusion in the rat. Biochem. Biophys. Res. Commun. 182:1992;1201-1217.
19. Cohen J.J. Apoptosis. Immunol. Today. 14:1993;126-130.
20. Colbourne F., Sutherland G.R., Auer R.N. Electron microscopic evidence against apoptosis as the mechanism of neuronal death in global ischemia. J. Neurosci. 19:1999;4200-4210.
21. Croall D.E., Demartino G.N. Calcium-activated neutral protease (calpain) system structure, function, and regulation . Phys. Rev. 71:1991;813-847.
22. Crumrine R.C., Thomas A.L., Morgan P.F. Attenuation of p53 expression protects against focal ischemic damage in transgenic mice. J. Cereb. Blood Flow Metab. 14:1994;887-891.
23. Datta R., Kojima H., Yoshida K., Kufe D. Caspase-3-mediated cleavage of protein kinase C theta in induction of apoptosis. J. Biol. Chem. 15:(272):1997;20317-20320.
24. Deshpande J., Bergstedt K., Linden T., Kalimo H., Wieloch T. Ultrastructural changes in the hippocampal CA1 region following transient cerebral ischemia evidence against programmed cell death . Exp. Brain. Res. 88:1992;91-105.
25. Deveraux Q.L., Takahashi R., Salvesen G.S., Reed J.C. X-linked IAP is a direct inhibitor of cell-death proteases. Nature. 388:1997;300-304.
26. Dosemeci A., Reese T.S. Effect of calpain on the composition and structure of postsynaptic densities. Synapse. 20:1995;91-97.
27. Egushi Y., Shimizu S., Tsujimoto Y. Intracellular ATP levels determine cell death fate by apoptosis or necrosis. Cancer Res. 57:1997;1835-1840.
28. 2+-dependent proteolysis during myoblast fusion. Biol. Cell. 85:1995;177-183.
29. Elvira M., Diez J.A., Wang K.K., Villalobo A. Phosphorylation of connexin-32 by protein kinase C prevents its proteolysis by mu-calpain and m-calpain. J. Biol. Chem. 268:1993;14294-14300.
30. Enders M., Wang Z.Q., Namura S., Waeber C., Moskowitz M. Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase. J. Cereb. Blood Flow Metab. 17:1997;1143-1151.
31. Enders M., Namura S., Shimizu-Sasamata M., Waeber C., Zhang L., Gomez-Isla T., Hyman B., Moskowitz M. Attenuation of delayed neuronal death after mild focal ischemia in mice by inhibition of the caspase family. J. Cereb. Blood Flow Metab. 18:1998;238-247.
32. Figueriredo-Pereira M.E., Banik N., Wilk S. Comparison of the effects of calpain inhibitors on two extralysosomal proteinases the multicatalytic proteinase complex and m-calpain . J. Neurochem. 62:1994;1989-1994.
33. Friedlander R.M., Yuan J. ICE, neuronal apoptosis and neurodegeneration. Cell Death Differ. 5:1998;823-831.
34. Friedlander R.M., Gagliardini V., Hara H., Fink K.B., Li W., MacDonald G., Fishman M.C., Greenberg A.H., Moskowitz M.A., Yuan J. Expression of a dominant negative mutant of ICE in transgenic mice prevents neuronal cell death induced by trophic factor withdrawal and ischemic brain injury. J. Exp. Med. 185:1997;933-940.
35. Fukuda K. Apoptosis-associated cleavage of beta-catenin in human colon cancer and rat hepatoma cells. Int. J. Biochem. Cell Biol. 31:1999;519-529.
36. Gao W.D., Atar D., Liu Y., Perez N.G., Murphy A.M., Marban E. Role of troponin I proteolysis in the pathogenesis of stunned myocardium. Circ. Res. 80:1997;393-399.
37. Ghayur T., Hugunin M., Talanian R.V., Ratnofsky S., Quinlan C., Emoto Y., Pandey P., Datta R., Huang Y., Kharbanda S., Allen H., Kamen R., Wong W., Kufe D. Proteolytic activation of protein kinase C delta by an ICE/CED 3-like protease induces characteristics of apoptosis. J. Exp. Med. 184:1996;2399-2404.
38. Greenwood A.F., Jope R.S. Brain G-protein proteolysis by calpain enhancement by lithium . Brain Res. 636:1994;320-326.
39. Gressner A.M., Lahme B., Roth S. Attenuation of TGF-beta-induced apoptosis in primary cultures of hepatocytes by calpain inhibitors. Biochem. Biophys. Res. Commun. 231:1997;457-462.
40. Haug L.S., Ostvold A.C., Cowburn R.F., Garlind A., Winblad B., Bogdanovich N., Walaas S.I. Decreased inositol (1,4,5)-trisphosphate receptor levels in Alzheimer's disease cerebral cortex: selectivity of changes and possible correlation to pathological severity. Neurodegeneration. 5:1996;169-176.
41. Hashimoto M., Inoue S., Ogawa S., Conrad C., Muramatsu M., Shackelford D., Masliah E. Rapid fragmentation of vimentin in human skin fibroblasts exposed to tamoxifen a possible involvement of caspase-3 . Biochem. Biophys. Res. Commun. 247:1998;401-406.
42. Hermann D.M., Kuroiwa T., Hata R., Gillardon F., Ito U., Mies G. Expression of redox factor-1, p53-activated gene 608 and caspase-3 messenger RNAs following repeated unilateral common carotid artery occlusion in gerbils relationship to delayed cell injury and secondary failure of energy state . Neuroscience. 102:2001;779-787.
43. Hoffman M.C., Nitsch C., Scotti A.L., Reinhard E., Monrad D. The prolonged presence of glia-derived nexin, an endogenous protease inhibitor, in the hippocampus after ischemia-induced delayed neuronal death. Neuroscience. 49:1992;397-408.
44. Hong S.C., Goto Y., Lanzino G., Soleau S., Kassel N.F., Lee K.S. Neuroprotection with calpain inhibitor in a model of focal cerebral ischemia. Stroke. 25:1994;663-669.
45. Horikawa Y., Oda N., Cox N.J., Li X., Orho-Melander M., Hara M., Hinokio Y., Lindner T.H., Mashima H., Schwarz P.E., del Bosque-Plata L., Horikawa Y., Oda Y., Yoshiuchi I., Colilla S., Polonsky K.S., Wei S., Concannon P., Iwasaki N., Schulze J., Baier L.J., Bogardus C., Groop L., Boerwinkle E., Hanis C.L., Bell G.L. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat. Genet. 26:2000;163-175.
46. Hu, B.R., Liu, C.L., Ouyang, Y., Blomgren, K., Siesjo, B.K., 2000. Involvement of caspase-3 in cell death after hypoxia-ischemia declines during brain maturation. Cereb. Blood Flow Metab 20, 1294-1300.
47. Ishisaka R., Utsumi T., Yabuki M., Kanno T., Furuno T., Inoue M., Utsumi K. Activation of caspase-3-like protease by digitonin-treated lysosomes. FEBS Lett. 435:1998;233-236.
48. Ivins K.J., Bui E.T., Cotman C.W. Beta-amyloid induces local neurite degeneration in cultured hippocampal neurons evidence for neuritic apoptosis . Neurobiol. Dis. 5:1998;365-378.
49. Johnson G.V., Litersky J.M., Jope R.S. Degradation of microtubule-associated protein 2 and brain spectrin by calpain a comparative study . J. Neurochem. 56:1991;1630-1638.
50. Jordan J., Galindo M.F., Miller R. Role of calpain- and interleukin-1β Converting enzyme-like proteases in the β-amyloid-induced death of rat hippocampal neurons in culture. J. Neurochem. 68:1997;1612-1621.
51. Jover T., Tanaka H., Calderone A., Oguro K., Bennett M.V., Etgen A.M., Zukin R.S. Estrogen protects against global ischemia-induced neuronal death and prevents activation of apoptotic signaling cascades in the hippocampal CA1. J. Neurosci. 22:2002;2115-2124.
52. Kakkar R., Radhi J.M., Rajala R.V., Sharma R.K. Altered expression of high-molecular-weight calmodulin-binding protein in human ischaemic myocardium. J. Pathol. 191:2000;208-216.
53. Kim T.W., Pettingell W.H., Jung Y.K., Kovacs D.M., Tanzi R.E. Alternative cleavage of Alzheimer-associated presenilins during apoptosis by a caspase-3 family protease. Science. 277:1997;373-376.
54. Kirino T. Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res. 239:1982;57-69.
55. Kubbutat M.H., Vousden K.H. Proteolytic cleavage of human p53 by calpain a potential regulator of protein stability . Mol. Cell. Biol. 17:1997;460-468.
56. Kuida K., Zheng T.S., Na S.K., Kuan D., Karasuyama H., Rakic P., Flavell R.A. Decreased apoptosis in the brain and premature lethality in CPP32 deficient mice. Nature. 384:1996;368-372.
57. Lankiewicz S., Marc Luetjens C., Truc Bui N., Krohn A.J., Poppe M., Cole G.M., Saido T.C., Prehn J.H. Activation of calpain I converts excitotoxic neuron death into a caspase-independent cell death. J. Biol. Chem. 275:2000;17064-17071.
58. Lee K.S., Frank S., Vanderklisch P., Arai A., Lynch G. Inhibition of proteolysis protects hippocampal neurons from ischemia. Proc. Natl. Acad. Sci. USA. 88:1991;7233-7237.
59. Leist M., Nicotera P. Apoptosis, excitotoxicity and neuropathology. Exp. Cell Res. 239:1998;183-201.
60. Leist M., Volbracht C., Kühnle S., Fava E., Ferrando-May E., Nicotera P. Caspase-mediated apoptosis in neuronal excitotoxicity triggered by nitrix oxide. Mol. Med. 3:1997;750-764.
61. MacManus J.P., Buchan A.M. Apoptosis after experimental stroke fact or fashion? J. Neurotrauma. 17:2000;899-914.
62. Markgraf C.G., Velayo N.L., Johnson M.P., McCarty D.R., Mehdi S., Koehl J.R., Chmielewski P.A., Linnik M.D. Six-hour window of opportunity for calpain inhibition in focal cerebral ischemia in rats. Stroke. 29:1998;152-158.
63. Martin S.J., Green D.R. Protease activation during apoptosis death by a thousand cuts? Cell. 82:1995;349-352.
64. Marzo I., Brenner C., Zamzami N., Susin S.A., Beutner G., Brdiczka D., Remy R., Xie Z.-H., Reed J.C., Kroemer G. The permeability transition pore complex a target for apoptosis regulation by caspases and Bcl-2-realted proteins . J. Exp. Med. 187:1998;1261-1271.
65. Mashima T., Naito M., Fujita N., Noguchi K., Tsuruo T. Identification of actin as a substrate of ICE and an ICE-like protease and involvement of an ICE-like protease but not ICE in VP-16-induced U937 apoptosis. Biochem. Biophys. Res. Commun. 217:1995;1185-1192.
66. Mashima T., Naito M., Noguchi K., Miller D.K., Nicholson D.W., Tsuruo T. Actin cleavage by CPP-32/apopain during the development of apoptosis. Oncogene. 14:1997;1007-1012.
67. Mattson M.P., Keller J.N., Begley J.G. Evidence for synaptic apoptosis. Exp. Neurol. 153:1998;35-48.
68. McGahan L., Hakim A.M., Robertson G.S. Hippocampal Myc and p53 expression following transient global ischemia. Brain Res. Mol. Brain Res. 56:1998;133-145.
69. McGinnis K.M., Gnegy M.E., Park Y.H., Mukerjee N., Wang K.K. Procaspase-3 and poly(ADP)ribose polymerase (PARP) are calpain substrates. Biochem. Biophys. Res. Commun. 263:1999;94-99.
70. Mellgren R.L. Evidence for participation of a calpain-like cysteine protease in cell cycle progression through late G1 phase. Biochem. Biophy. Res. Commun. 236:1997;555-558.
71. Melloni E., Pontremolli S. The calpain calpastatin system structural and functional properties . J. Nutr. Biochem. 2:1991;467-476.
72. Melloni E., De Tullio R., Averna M., Tedesco I., Salamino F., Sparatore B., Pontremoli S. Properties of calpastatin forms in rat brain. FEBS Lett. 10:1998;55-58.
73. Meredith J. Jr., Mu Z., Saido T., Du X. Cleavage of the cytoplasmic domain of the integrin beta3 subunit during endothelial cell apoptosis. J. Biol. Chem. 273:1998;19525-19531.
74. Molinari M., Anagli J., Carafoli E. PEST sequences do not influence substrate susceptibility to calpain proteolysis. J. Biol. Chem. 270:1995;2032-2035.
75. Murachi T. Intracellular regulatory systems involving calpain and calpastatin. Biochem. Int. 18:1989;263-294.
76. Nakagawa T., Yuan J. Cross-talk between two cysteine protease families. Activation of caspase-12 by calpain in apoptosis. J. Cell. Biol. 150:2000;887-894.
77. Namura S., Zhu J., Fink K., Endres M., Srinivasan A., Tomaselli K.J., Yuan J., Moskowitz M.A. Activation and cleavage of caspase-3 in apoptosis induced by experimental cerebral ischemia. J. Neurosci. 18:1998;3659-3668.
78. Nath R., Raser K.J., McGinnis K., Nadimpalli R., Stafford D., Wang K.K. Effects of ICE-like protease and calpain inhibitors on neuronal apoptosis. Neuroreport. 8:1996;249-255.
79. Nicotera P., Leist M., Manzo L. Neuronal cell death a demise with different shapes . TIPS. 20:1999;46-51.
80. Nicotera P., Leist M., Single B., Vollbracht C. Execution of apoptosis converging or diverging pathways? Biol. Chem. 380:1999;1035-1040.
81. Nitatori T., Sato N., Waguri S., Karasawa Y., Araki H., Shibanai K., Kominami E., Uchiyama Y. Delayed neuronal death in the CA1 pyramidal cell layer of the gerbil hippocampus following transient ischemia is apoptosis. J. Neurosci. 15:1995;1001-1011.
82. Niwa M., Hara A., Iwai T., Wang S., Hotta K., Mori H., Uematsu T. Caspase activation as an apoptotic evidence in the gerbil hippocampal CA1 pyramidal cells following transient forebrain ischemia. Neurosci. Lett. 300:2001;103-106.
83. Nixon R.A. A "protease activation cascade" in the pathogenesis of Alzheimer's disease. Ann. NY Acad. Sci. 924:2000;117-131.
84. Ohtsu M., Sakai N., Fujita H., Kashiwagi M., Gasa S., Shimizu S., Eguchi Y., Tsujimoto Y., Sakiyama Y., Kobayashi K., Kuzumaki N. Inhibition of apoptosis by the actin-regulatory protein gelsolin. EMBO J. 16:1997;4650-4656.
85. Palm D.E., Knuckey N.W., Primiano M.J., Spangenberger A.G., Johansen C.E. Cystatin C, a protease inhibitor, in degenerating rat hippocampal neurons following transient forebrain ischemia. Brain Res. 691:1995;1-8.
86. Parr T., Bardsley R.G., Gilmour R.S., Buttery P.J. Changes in calpain and calpastatin mRNA induced by beta-adrenergic stimulation of bovine skeletal muscle. Eur. J. Biochem. 208:1992;333-339.
87. Pellegrini-Giampietro D.E., Gorter J.A., Bennett M.V., Zukin R.S. The GluR2 (GluR-B) hypothesis Ca(2+)-permeable AMPA receptors in neurological disorders . Trends Neurosci. 20:1998;464-470.
88. Pulsinelli W.A., Brierley J.B., Plum F. Temporal profile of neuronal damage in a model of transient forebrain ischemia. Ann. Neurol. 1:1982;491-498.
89. Raff M.C., Barres B.A., Burne J.F., Coles H.S., Ishizaki Y., Jacobson M.D. Programmed cell death and the control of cell survival lessons from the nervous system . Science. 262:1993;695-700.
90. Rami A. Cross-talk between calpain and caspase-3 in response to cerebral ischemia. Restorative Neurol. Neurosci. 16:2000;63.
91. Rami A., Krieglstein J. Protective effects of calpain inhibitors against neuronal damage caused by cytotoxic hypoxia in vitro and ischemia in vivo. Brain Res. 609:1993;67-70.
92. Rami A., Krieglstein J. Inhibition of proteolysis prevents neuronal damage caused by cytotoxic hypoxia or ischemia. Krieglstein J., Oberpichler H. Pharmacology of Cerebral Ischemia. 1993;301-307 Wiss. Verlagsges, Stuttgart.
93. Rami A., Krieglstein J. Inhibition of proteolysis protects neurons against damage caused hypoxia or ischemia. J. Cereb. Blood Flow Metab. 13:(Suppl. 1):1993;646.
94. Rami A., Krieglstein J. Brain damage caused by ischemia pathophysiological and pharmacological aspects . Dementia. 4:1993;21-31.
95. Rami A., Krieglstein J. Neuronal protective effects of calcium antagonists in cerebral ischemia. Life Sci. 55:1994;2105-2113.
96. Rami A., Rabie A., Thomasset M., Krieglstein J. Calbindin-D28K and ischemic damage of pyramidal cells in rat hippocampus. J. Neurosci. Res. 31:1992;89-95.
97. Rami A., Ferger D., Krieglstein J. Blockade of proteolytic activity rescues neurons from glutamate excitotoxicity. Neurosci. Res. 27:1997;93-97.
98. Rami A., Agarwal R., Botez G., Winckler J. μ-Calpain activation, DNA-fragmentation, and synergistic effects of caspase- and calpain-inhibitors in protecting hippocampal neurons from ischemic damage. Brain Res. 866:2000;299-312.
99. Ray S.K., Patel S.J., Welsh C.T., Wilford G.G., Hogan E.L., Banik N.L. Molecular evidence of apoptotic death in malignant brain tumors including glioblastoma multiforme upregulation of calpain and caspase-3 . J. Neurosci. Res. 69:2002;197-206.
100. Richard I., Broux O., Allamand V., Fougerousse F., Chiannilkulchai N., Bourg N., Brenguier L., Devaud C., Pasturaud P., Roudaut C. Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A. Cell. 81:1995;27-40.
101. Roberts-Lewis J.M., Marcy V.R., Zhao Y., Vaught J.L., Siman R., Lewis M.E. Aurintricarboxylic acid protects hippocampal neurons from NMDA- and ischemia-induced toxicity in vivo. J. Neurochem. 61:1993;378-381.
102. Roy N., Deveraux Q.L., Takahashi R., Salvesen G.S., Reed J.C. The cIAP-1 and cIAP-2 proteins are direct inhibitors of specific caspases. EMBO J. 16:1997;6914-6925.
103. Ruiz-Vela A., Gonzalez de Buitrago G., Martinez A.C. Implication of calpain in caspase activation during B cell clonal deletion. EMBO J. 18:1999;4988-4998.
104. Sadoul R., Quiquerez A.L., Martinou I., Fernandez P.A., Martinou J.C. P53 expression induces apoptosis in hippocampal pyramidal neuron cultures. J. Neurosci. 17:1996;1397-1405.
105. Saido T.C., Yokota M., Nagao N., Yamaura I., Tani E., Tsuchiya T., Suzuki K., Kawashima S. Spatial resolution of spectrin proteolysis in postischemic brain. J. Biol. Chem. 25:1993;25239-25243.
106. Saido T.C., Sorimachi H., Suzuki K. Calpain new perspectives in molecular diversity and physiological-pathological involvement . FASEB J. 8:1994;814-822.
107. Saido T.C., Kwashima S., Tani E., Yokta M. Up- and downregulation of calpain inhibitor polypeptide, calpastatin, in postischemic hippocampus. Neurosci. Lett. 227:1997;756-778.
108. Sakahira H., Enari M., Nagata S. Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature. 91:1998;96-99.
109. Schielke G.P., Yang G.Y., Shivers B.D., Betz A.L. Reduced ischemic brain injury in interleukin-1 beta converting enzyme-deficient mice. J. Cereb. Blood Flow Metab. 18:1998;180-185.
110. See V., Loeffler J.P. Oxidative stress induces neuronal death by recruiting a protease and phosphatase-gated mechanism. J. Biol. Chem. 276:2001;35049-35059.
111. Shiba E., Kim S.J., Kambayashi J., Kawamura I., Lacey E., Manda T., Shimomura K., Taguchi T., Takai S. Mechanism of growth inhibition by calpain inhibitor in MCF-7 cells. Anticancer Res. 17:1997;1919-1923.
112. Shields D.C., Banik N.L. Pathophysiological role of calpain in experimental demyelination. J. Neurosci. Res. 55:1999;533-541.
113. Shields D.C., Schaecher K.E., Saido T.C., Banik N.L. A putative mechanism of demyelination in multiple sclerosis by a proteolytic enzyme, calpain. Proc. Natl. Acad. Sci. USA. 96:1999;11486-11491.
114. Siesjö B.K. Cell damage in the brain a speculative synthesis . J. Cereb. Blood Flow Metab. 1:1981;155-185.
115. Siman R. Role of calpain I in excitatory amino-acid induced degenerative structural changes. Guidotti A. Neurotoxicity of Excitatory Amino Acids. 1990;145-161 Raven, New York.
116. Siman R., Nosek J.C., Kegerise C. Calpain I activation is specifically related to excitatory amino acid induction of hippocampal damage. J. Neurosci. 9:1989;1579-1590.
117. Spinedi A., Oliverio S., Di Sano F., Piacentini M. Calpain involvement in calphostin C-induced apoptosis. Biochem. Pharmacol. 56:1998;1489-1492.
118. Squier K.T.M., Miller A.C.K., Malkinson A.M., Cohen J.J. Calpain activation in apoptosis. J. Cell Physiolo. 159:1994;229-237.
119. Srinivasan A., Roth K.A., Sayers R.O., Shindler K.S., Wong A.M., Fritz L.C., Tomaselli K.J. In situ immunodetection of activated caspase-3 in apoptotic neurons in the developing nervous system. Cell Death Differ. 5:1998;1004-1016.
120. Steller H. Mechanisms and genes of cellular suicide. Science. 267:1995;1445-1449.
121. Takahashi A., Earnshaw W. ICE-related proteases in apoptosis. Curr. Opin. Genet. Dev. 6:1996;50-55.
122. Takahashi A., Musy P.Y., Martins L.M., Poirier G.G., Moyer R.W., Earnshaw W.C. CrmA/SPI-2 inhibition of an endogenous ICE-related protease responsible for lamin A cleavage and apoptotic nuclear fragmentation. J. Biol. Chem. 271:1996;32487-32490.
123. Thomas A., El Rouby S., Reed J.C., Krajewski S., Silber R., Potmesil M., Newcomb E.W. Drug-induced apoptosis in B-cell chronic lymphocytic leukemia relationship between p53 gene mutation and bcl-2/bax proteins in drug resistance . Oncogene. 12:1996;1055-1062.
124. Tsuji T., Shimohama S., Kimura J., Shimizu K. m-Calpain (calcium-activated neutral proteinase) in Alzheimer's disease brains. Neurosci. Lett. 248:1998;109-112.
125. Vanagts D.M., PormAres M.I., Coppola S., Burgess D.H., Orrenius S. Protease involvement in spectrin cleavage and phosphatidylserine exposure in apoptosis. J. Biol. Chem. 271:1996;31075-31085.
126. Vancompernolle K., Van Herreweghe F., Pynaert G., Van de Craen M., De Vos K., Totty N., Sterling A., Fiers W., Vandenabeele P., Grooten J. Atractyloside-induced release of cathepsin B, a protease with caspase-processing activity. FEBS Lett. 438:1998;150-158.
127. Villa P.G., Henzel W.J., Sensenbrenner M., Henderson C.E., Pettmann B. Calpain inhibitors, but not caspase inhibitors, prevent actin proteolysis and DNA fragmentation during apoptosis. J. Cell Sci. 111:1998;713-722.
128. Wakade A.R., Przywara D.A., Palmer K.C., Kulkarni J.S., Wakade T.D. Deoxynucleoside induces neuronal apoptosis independent of neurotrophic factors. J. Biol. Chem. 270:1995;17986-17992.
129. Wang K.K.W., Posmantur R., Nadimpalli R., Nath R., Mohan P., Nixon R., Talanian R.V., Keegan M., Herzog L., Allen H. Caspase-mediated fragmentation of calpain inhibitor protein calpastatin during apoptosis. Arch. Biochem. Biophys. 356:1998;187-196.
130. Waterhouse N.J., Finucane D.M., Green D.R., Elce J.S., Kumar S., Alnemri E.S., Litwack G., Khanna K., Lavin M.F., Watters D.J. Calpain activation is upstream of caspases in radiation-induced apoptosis. Cell Death Differ. 5:1998;1051-1061.
131. Widmann C., Gibson S., Johnson G.L. Caspase-dependent cleavage of signaling proteins during apoptosis. A turn-off mechanism for anti-apoptotic signals. J. Biol. Chem. 273:1998;7141-7147.
132. Yamashima T. Implication of cysteine proteases calpain, cathepsin and caspase in ischemic neuronal death of primates. Prog. Neurobiol. 62:2000;273-295.
133. 2+, PIP2 and calpain responses prior to delayed neuronal death in monkeys. Eur. J. Neurosci. 8:1996;1932-1944.
134. Yoshida K. Myocardial ischemia-reperfusion injury and proteolysis of fodrin, ankyrin, and calpastatin. Methods Mol. Biol. 144:2000;267-275.
135. Yoshimoto R., Hori M., Ozaki H., Karaki H. Proteolysis of acidic calponin by mu-calpain. J. Biochem. 128:2000;1045-1049.
136. Zou H., Henzel W.J., Liu X., Lutschg A., Wang X. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell. 90:1997;405-413.